Physician profile
Peter Michael
NPI 1972898815
$4,797.43
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,592 · 2020: $126 · 2021: $211 · 2022: $1,542 · 2023: $228 · 2024: $98.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $287 · Travel and Lodging: $40.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $287.15 |
| Travel and Lodging | $40.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Konica Minolta Healthcare Americas, INC | $2,500.00 | 2019 | |
| Nalu Medical, INC. | $1,439.29 | 2022-2024 | Nalu Neurostimulation System |
| Abbott Laboratories | $218.54 | 2021-2024 | Eterna |
| Almatica Pharma LLC | $151.42 | 2022-2023 | Gralise |
| Scilex Pharmaceuticals INC. | $129.71 | 2021-2023 | Ztlido |
| Philips North America LLC | $101.38 | 2020 | |
| Vertiflex, INC. | $91.68 | 2019 | |
| Saluda Medical Americas, INC. | $79.52 | 2023 | Evoke Scs |
| Boston Scientific Corporation | $48.28 | 2023 | Wavewriter Alpha Prime 16 |
| Fidia Pharma USA INC. | $24.25 | 2020 | |
| Intrinsic Therapeutics | $13.36 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Michael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.